Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia

Lignende værker

• Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
  af: Harinder Gill, et al.
  Udgivet: (2016-03-01)
• Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
  af: Gill, Harinder, et al.
  Udgivet: (2016)
• Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia
  af: Sun, Jie, et al.
  Udgivet: (2016)
• Remission of psoriasis during treatment with sorafenib
  af: van Kester, Marloes S., et al.
  Udgivet: (2018)
• Very long-term remission with azacitidine in VEXAS syndrome
  af: Lin-Pierre Zhao, et al.
  Udgivet: (2025-01-01)